Results 151 to 160 of about 961,470 (198)
Some of the next articles are maybe not open access.
Leukemia & Lymphoma, 2007
Plasma cell leukemia represents a unique subset of patients with multiple myeloma. The definition requires that: (i) for a blood leukocyte count of >10 000/µl, at least 2000/µl are circulating plas...
openaire +2 more sources
Plasma cell leukemia represents a unique subset of patients with multiple myeloma. The definition requires that: (i) for a blood leukocyte count of >10 000/µl, at least 2000/µl are circulating plas...
openaire +2 more sources
Plasma cell dyscrasias and leukemias
Update on Cancer Therapeutics, 2005Abstract There has been remarkable progress in our understanding of plasma cell dyscrasias and leukemias in recent years. New prognostic factors have come to light. Del(1)(p12) and t(4;14) confer poor prognoses on patients with myeloma. COX-2 positivity is associated with poorer progression-free and overall survival in myeloma patients and a role for
openaire +2 more sources
2017
Primary plasma cell leukemia (pPCL) is a de novo presentation of an aggressive extramedullary myeloma characterized by circulating plasma cells in peripheral blood. The clonal plasma cells may accumulate genetic aberrations rapidly in a very short period, resulting in de novo pPCL (from monoclonal gammopathy of undetermined significance to pPCL ...
Nisha S. Joseph +2 more
openaire +2 more sources
Primary plasma cell leukemia (pPCL) is a de novo presentation of an aggressive extramedullary myeloma characterized by circulating plasma cells in peripheral blood. The clonal plasma cells may accumulate genetic aberrations rapidly in a very short period, resulting in de novo pPCL (from monoclonal gammopathy of undetermined significance to pPCL ...
Nisha S. Joseph +2 more
openaire +2 more sources
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1989
The following article describes five patients with plasma cell leukemia treated during the last two years at a Medical University Polyclinic. Plasma cell leukemia is a disease which was seen extremely rarely in the past. The disease can develop in patients with multiple myeloma or, even more rarely, as a "de novo" disease.
F, Egli, K, Rhyner
openaire +1 more source
The following article describes five patients with plasma cell leukemia treated during the last two years at a Medical University Polyclinic. Plasma cell leukemia is a disease which was seen extremely rarely in the past. The disease can develop in patients with multiple myeloma or, even more rarely, as a "de novo" disease.
F, Egli, K, Rhyner
openaire +1 more source
Bulletin du cancer, 2015
Plasma cell leukemia (PCL) is a rare disorder which develops spontaneously (primary PCL) or evolves in patients with multiple myeloma (secondary PCL). It is defined by the presence of 2 × 10(9)/L peripheral blood plasma cells or plasmacytosis accounting for more than 20 % of the differential white cell count.
Aurélie, Ravinet +2 more
openaire +1 more source
Plasma cell leukemia (PCL) is a rare disorder which develops spontaneously (primary PCL) or evolves in patients with multiple myeloma (secondary PCL). It is defined by the presence of 2 × 10(9)/L peripheral blood plasma cells or plasmacytosis accounting for more than 20 % of the differential white cell count.
Aurélie, Ravinet +2 more
openaire +1 more source
2016
Plasma cell leukemia (PCL) is a rare and aggressive form of multiple myeloma (MM). It is characterized by the presence of a large number of circulating clonal plasma cells. It is comprised of two forms: (1) primary PCL (pPCL) which originate de novo with no prior history of MM and (2) secondary PCL (sPCL) where patients with a prior history of MM ...
Wilson I. Gonsalves, Shaji K. Kumar
openaire +1 more source
Plasma cell leukemia (PCL) is a rare and aggressive form of multiple myeloma (MM). It is characterized by the presence of a large number of circulating clonal plasma cells. It is comprised of two forms: (1) primary PCL (pPCL) which originate de novo with no prior history of MM and (2) secondary PCL (sPCL) where patients with a prior history of MM ...
Wilson I. Gonsalves, Shaji K. Kumar
openaire +1 more source
Seminars in hematology, 1987
In summary, plasma cell leukemia is a rare disorder that can develop spontaneously or evolve in patients with multiple myeloma. The diagnosis is based on laboratory features, including a plasmacytosis exceeding 2 X 10(9)/L or 20% of the differential cell count.
M A, Kosmo, R P, Gale
openaire +1 more source
In summary, plasma cell leukemia is a rare disorder that can develop spontaneously or evolve in patients with multiple myeloma. The diagnosis is based on laboratory features, including a plasmacytosis exceeding 2 X 10(9)/L or 20% of the differential cell count.
M A, Kosmo, R P, Gale
openaire +1 more source
Archives of Pathology & Laboratory Medicine, 2010
D. Krause, T. Spitzer, C. Stowell
semanticscholar +1 more source
D. Krause, T. Spitzer, C. Stowell
semanticscholar +1 more source
The American Journal of the Medical Sciences, 1958
L S, RALSTON, W A, WASDAHL, A K, SAIKI
openaire +2 more sources
L S, RALSTON, W A, WASDAHL, A K, SAIKI
openaire +2 more sources